EAACI Launches Global Antibiotic Allergy Awareness Campaign At EAACI Congress 2025
A Global Call to Action
Antibiotic allergy mislabelling affects millions worldwide. Inaccurate labels lead to avoidance of first-line treatments and overuse of second-line antibiotics, fuelling AMR. EAACI calls on all stakeholders to promote accurate diagnosis and responsible antibiotic use.
“We are launching a movement - not a moment,” said Maria Torres, EAACI President.“Too many lives are impacted by unverified allergy labels that limit treatment options and worsen health outcomes. This campaign builds momentum to correct labels, improve safety, and preserve antibiotics for future generations. Correcting labels means saving lives - now and in the future.”
The Campaign's Objectives:
- Raise awareness about the dangers of incorrect antibiotic allergy labels Empower patients and healthcare professionals with tools and training Promote evidence-based allergy evaluation protocols Encourage rational antibiotic prescribing to protect long-term efficacy
Breaking Down the Barriers
Many patients carry outdated, unverified, or self-reported allergy labels, reducing treatment options and increasing risk. The campaign tackles these issues through education, training, and advocacy.
Resources to Drive Change
A central feature of the campaign is a short educational video explaining antibiotic allergy and why correct labels matter. The Promotional Kit 2025 offers tools to amplify the campaign across all platforms.
Join the Movement
Launched under the slogan “Correct Labels, Better Lives,” the campaign invites professionals, educators, institutions, and individuals to join the global awareness effort. Together, we can protect the effectiveness of antibiotics.
Explore the campaign and download resources:
About EAACI
The European Academy of Allergy and Clinical Immunology (EAACI) is Europe's largest professional association in the field, committed to advancing research and care for those affected by allergic diseases.
Learn more:
Contact: ... | +41 44 205 55 33
A photo accompanying this announcement is available at


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Utila Triples Valuation In Six Months As Stablecoin Infrastructure Demand Triggers $22M Extension Round
- Cregis Joins TOKEN2049 Singapore 2025
- Jpmorgan Product Head Joins GSR Trading MD To Build Institutional Staking Markets
- Stratx Launches Compliance-Aware Routing Protocol For Stablecoins, Rwas, And Cross-Border Settlement
- “Farewell To Westphalia” Explores Blockchain As A Model For Post-Nation-State Governance
- DOLLUM Expands Wallet Opportunities, Introducing New Security Features Following The DOL Token Sale
Comments
No comment